Stanley J. Meresman - Mar 10, 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Director
Signature
/s/ John Saia, as attorney-in-fact for Stanley J Meresman
Stock symbol
GH
Transactions as of
Mar 10, 2022
Transactions value $
-$289,823
Form type
4
Date filed
3/14/2022, 08:17 PM
Previous filing
Mar 2, 2022
Next filing
May 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $29.3K +4.93K +121.56% $5.94 8.99K Mar 10, 2022 Direct
transaction GH COMMON STOCK Sale -$290K -4.93K -54.86% $58.74 4.06K Mar 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Options Exercise -$29.3K -4.93K -33.33% $5.94 9.87K Mar 10, 2022 COMMON STOCK 4.93K $5.94 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
F2 The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018.